COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study. - Kueper JK; Kottilil K; Quer G; Chiang DC; Spencer EG; Purushotham J; Ramos E; Roumani L; Andersen KG; Topol EJ; Pandit JA; Mina MJ (Interactive journal of medical research, 2026)